Business · 14/08/2019Updated: 10/17/2026 · 1 min read
FDA Announces Draft Guidance for Gastroparesis Treatment
Summary
The US Food and Drug Administration (FDA) has released a draft guidance document outlining its recommendations for clinical trials and endpoint assessments to develop new treatments for diabetic and idiopathic gastroparesis, a condition affecting stomach motility.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →